Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Uterine Cervical Neoplasms × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

OTHER 7 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fallopian Tube Neoplasms 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Oesophagogastric Cancer 1 Neoplasms, Squamous Cell 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

Cisplatin 6 Radiotherapy 4 Hydralazine 3 Gemcitabine 3 Valproic Acid 2 Probiotics 2 Paclitaxel 2 Drug Therapy 2 Brachytherapy 2 spartalizumab 1 nimotuzumab 1 belotecan 1 apatinib 1 Therapeutics 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiotherapy, Intensity-Modulated 1 Radiation Dose Hypofractionation 1 Proto-Oncogene Proteins c-raf 1 Neoadjuvant Therapy 1 Nelfinavir 1 Mobile Health Units 1 Magnetic Resonance Spectroscopy 1 Magnesium 1 Injections 1 Immune Checkpoint Inhibitors 1 Hysteroscopy 1 Heart Rate 1 Fatty Acids, Omega-3 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00193739 2019-09-20

NACTcervix

Tata Memorial Hospital

Phase 3 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡